[{"Assets_0_Q2_USD":295236000.0,"CommonStockSharesOutstanding_0_Q2_shares":36740000.0,"EarningsPerShareBasic_1_Q2_USD":-0.09,"EarningsPerShareBasic_2_Q2_USD":-0.42,"EarningsPerShareDiluted_1_Q2_USD":-0.09,"EarningsPerShareDiluted_2_Q2_USD":-0.42,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-37942000.0,"NetIncomeLoss_1_Q2_USD":-3438000.0,"NetIncomeLoss_2_Q2_USD":-15674000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":29116000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":62277000.0,"StockholdersEquity_0_Q2_USD":78546000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":36772000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":37666000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":36772000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":37666000.0,"Ticker":"AVDL","CIK":"1012477","name":"AVADEL PHARMACEUTICALS PLC","OfficialName":"Avadel Pharmaceuticals plc American Depositary Shares","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"391383731.0","Country":"France","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180807"}]